Crossmark

Immune cell phenotypes and mortality in the Framingham Heart Study

Published Online: 2024-06-12

Authors

Ragab, Ahmed A. Y.

Doyle, Margaret F.

Chen, Jiachen

Fang, Yuan

Lunetta, Kathryn L.

Murabito, Joanne M.
Funding

Funding for this research was provided by:

National Institute on Aging (R01AG067457, R01AG067457, R01AG067457, R01AG067457, R01AG067457, R01AG067457)

The National Heart, Lung, and Blood Institute & Boston University FHS (75N92019D00031, 75N92019D00031, 75N92019D00031, 75N92019D00031, 75N92019D00031, 75N92019D00031)
License Information

Text and Data Mining valid from 2024-06-12

Version of Record valid from 2024-06-12
More Information

Article History

Received: 18 December 2023

Accepted: 23 April 2024

First Online: 12 June 2024

Declarations

:

: Each participant granted written informed consent during every FHS examination attended, a process assessed and approved by the Institutional Review Board (IRB) at Boston University Medical Center (BUMC). The existing IRB number for FHS at BUMC is H-32132, while for the current study, it is H-39876.

: N/A.

: The authors declare no competing interests.

Document is current